Abstract

Hydrogen sulfide (H2S) is a signaling gasotransmitter, involved in different physiological and pathological processes. H2S regulates apoptosis, the cell cycle and oxidative stress. H2S exerts powerful effects on smooth muscle cells, endothelial cells, inflammatory cells, endoplasmic reticulum, mitochondria and nuclear transcription factors. H2S is known to be produced from L-cysteine, D-cysteine and L-homocysteine in the body. Four enzymes – cystathionine-b synthase (CBS), mercaptopyruvate sulfurtransferase (3-MST), cystathionine-γ lyase (CSE) and cysteine aminotransferase (CAT) – are involved in H2S synthesis. The biosynthetic pathway for the production of H2S from D-cysteine involves 3-MST and D-amino acid oxidase (DAO). The therapeutic potential of H2S is not clear. However, recently results have demonstrated that H2S has protective action for ischemic heart disease or hypertension, and protects against ischemia of the brain. This review summarizes the negative and the positive roles of H2S in various biological systems, for example the cardiovascular system and nervous system. We also discuss the function of classical, therapeutic and natural (for example garlic) donors of H2S in pre-clinical and clinical studies.

References

• 1. Abe K., Kimura H.: The possible role of hydrogen sulfide as anendogenous neuromodulator. J. Neurosci., 1996; 16: 1066-1071
  Google Scholar
• 2. Attene-Ramos M.S., Wagner E.D., Plewa M.J., Gaskins H.R.: Evidencethat hydrogen sulfide is a genotoxic agent. Mol. Cancer Res.,2006; 4: 9-14
  Google Scholar
• 3. Bełtowski J.: Siarkowodór jako biologicznie aktywny mediatorw układzie krążenia. Postępy Hig. Med. Dośw., 2004; 58: 285-291
  Google Scholar
• 4. Chwatko G.: Oznaczanie siarkowodoru w próbkach biologicznych.Wiadom. Chem., 2010; 64: 243-262
  Google Scholar
• 5. Dello Russo C., Tringali G., Ragazzoni E., Maggiano N., Menini E.,Vairano M., Preziosi P., Navarra P.: Evidence that hydrogen sulphidecan modulate hypothalamo-pituitary-adrenal axis function: in vitroand in vivo studies in the rat. J. Neuroendocrinol., 2000; 12: 225-233
  Google Scholar
• 6. Di Masi A., Ascenzi P.: H2S: a “double face” molecule in healthand disease. Biofactors, 2013; 39: 186-196
  Google Scholar
• 7. Eto K., Ogasawara M., Umemura K., Nagai Y., Kimura H.: Hydrogensulfide is produced in response to neuronal excitation. J. Neurosci.,2002; 22: 3386-3391
  Google Scholar
• 8. Fiorucci S., Orlandi S., Mencarelli A., Caliendo G., Santagada V.,Distrutti E., Santucci L., Cirino G., Wallace J.L.: Enhanced activity ofa hydrogen sulphide-releasing derivative of mesalamine (ATB-429)in a mouse model of colitis. Br. J. Pharmacol., 2007; 150: 996-1002
  Google Scholar
• 9. Frantzias J., Logan J.G., Mollat P., Sparatore A., Del Soldato P.,Ralston S.H., Idris A.I.: Hydrogen sulphide-releasing diclofenac derivativesinhibit breast cancer-induced osteoclastogenesis in vitroand prevent osteolysis ex vivo. Br. J. Pharmacol., 2012; 165: 1914-1925
  Google Scholar
• 10. Hu L.F., Wong P.T., Moore P.K., Bian J.S.: Hydrogen sulfide attenuateslipopolysaccharide-induced inflammation by inhibition ofp38 mitogen-activated protein kinase in microglia. J. Neurochem.,2007; 100: 1121-1128
  Google Scholar
• 11. Kimura H.: Hydrogen sulfide induces cyclic AMP and modulatesthe NMDA receptor. Biochem. Biophys. Res. Commun., 2000;267: 129-133
  Google Scholar
• 12. Kimura H.: The physiological role of hydrogen sulfide and beyond.Nitric Oxide, 2014; 41: 4-10
  Google Scholar
• 13. Kubo S., Doe I., Kurokawa Y., Nishikawa H., Kawabata A.: Directinhibition of endothelial nitric oxide synthase by hydrogen sulfide:contribution to dual modulation of vascular tension. Toxicology,2007; 232: 138-146
  Google Scholar
• 14. Lee S.W., Hu Y.S., Hu L.F., Lu Q., Dawe G.S., Moore P.K., WongP.T., Bian J.S.: Hydrogen sulphide regulates calcium homeostasis inmicroglial cells. Glia, 2006; 54: 116-124
  Google Scholar
• 15. Lee Z.W., Zhou J., Chen C.S., Zhao Y., Tan C.H., Li L., Moore P.K.,Deng L.W.: The slow-releasing hydrogen sulfide donor, GYY4137,exhibits novel anti-cancer effects in vitro and in vivo. PLoS One,2011; 6: e21077
  Google Scholar
• 16. Li L., Salto-Tellez M., Tan C.H., Whiteman M., Moore P.K.:GYY4137, a novel hydrogen sulfide-releasing molecule, protectsagainst endotoxic shock in the rat. Free Radic. Biol. Med., 2009; 47:103-113
  Google Scholar
• 17. Łowicka E., Bełtowski J.: Hydrogen sulfide (H2S) – the third gas ofinterest for pharmacologists. Pharmacol. Rep., 2007; 59: 4-24
  Google Scholar
• 18. Magierowski M., Jasnos K., Kwiecień S., Brzozowski T.: Rola siarkowodoruw fizjologii przewodu pokarmowego i w mechanizmiegastroprotekcji. Postępy Hig. Med. Dośw., 2013; 67: 150-156
  Google Scholar
• 19. Malinowska J., Babicz K., Olas B.: Biologiczna aktywność siarkowodoru.Wiad. Chem., 2011; 65: 289-299
  Google Scholar
• 20. Mikami Y., Shibuya N., Ogasawara Y., Kimura H.: Hydrogen sulfideis produced by cystathionine γ-lyase at the steady-state lowintracellular Ca2+ concentrations. Biochem. Biophys. Res. Commun.,2013; 431: 131-135
  Google Scholar
• 21. Morel A., Malinowska J., Olas B.: Antioxidative properties ofhydrogen sulfide may involve in its antiadhesive action on bloodplatelets. Clin. Biochem., 2012; 45: 1678-1682
  Google Scholar
• 22. Morel A., Malinowska J., Olas B.: Hydrogen sulfide changes adhesiveproperties of fibrinogen and collagen in vitro. Platelets, 2014;25: 147-149
  Google Scholar
• 23. Olas B.: Hydrogen sulfide in hemostasis: friend or foe? Chem.Biol. Interact., 2014; 217: 49-56
  Google Scholar
• 24. Olas B., Kontek B.: The possible role of hydrogen sulfide as a modulatorof hemostatic parameters of plasma. Chem. Biol. Interact.,2014; 220: 20-24
  Google Scholar
• 25. Olson K.R., Healy M.J., Qin Z., Skovgaard N., Vulesevic B., DuffD.W., Whitfield N.L., Yang G., Wang R., Perry S.F.: Hydrogen sulfideas an oxygen sensor in trout gill chemoreceptors. Am. J. Physiol.Regul. Integr. Comp. Physiol., 2008; 295: R669-R680
  Google Scholar
• 26. Predmore B.L., Julian D., Cardounel A.J.: Hydrogen sulfide increasesnitric oxide production from endothelial cells by an Akt–dependent mechanism. Front. Physiol., 2011; 2: 104
  Google Scholar
• 27. Predmore B.L., Lefer D.J., Gojon G.: Hydrogen sulfide in biochemistryand medicine. Antioxid. Redox Signal., 2012; 17: 119-140
  Google Scholar
• 28. Shibuya N., Koike S., Tanaka M., Ishigami-Yuasa M., Kimura Y.,Ogasawara Y., Fukui K., Nagahara N., Kimura H.: A novel pathway forthe production of hydrogen sulfide from D-cysteine in mammaliancells. Nat. Commun., 2013; 4: 1366
  Google Scholar
• 29. Shibuya N., Mikami Y., Kimura Y., Nagahara N., Kimura H.: Vascularendothelium expresses 3-mercaptopyruvate sulfurtransferaseand produces hydrogen sulfide. J. Biochem., 2009; 146: 623-626
  Google Scholar
• 30. Shibuya N., Tanaka M., Yoshida M., Ogasawara Y., Togawa T.,Ishii K., Kimura H.: 3-Mercaptopyruvate sulfurtransferase produceshydrogen sulfide and bound sulfane sulfur in the brain. Antioxid.Redox Signal., 2009; 11: 703-714
  Google Scholar
• 31. Stetkiewicz J.: Siarkowodór. Podstawy i Metody Oceny ŚrodowiskaPracy, 2011; 4: 97-117
  Google Scholar
• 32. Szabó C.: Hydrogen sulphide and its therapeutic potential. Nat.Rev. Drug Discov., 2007; 6: 917-935
  Google Scholar
• 33. Tadeusiewicz J., Krysztofiak A., Olas B.: Czosnek – panaceum nachoroby układu krążenia? Kosmos, 2014; 63: 37-44
  Google Scholar
• 34. Tadeusiewicz J., Olas B.: Siarkowodór – gaz nie tylko o właściwościachtoksycznych. Kosmos, 2014; 63: 125-135
  Google Scholar
• 35. Tan B.H., Wong P.T., Bian J.S.: Hydrogen sulfide: a novel signalingmolecule in the central nervous system. Neurochem. Intern.,2010; 56: 3-10
  Google Scholar
• 36. Tang G., Wu L., Liang W., Wang R.: Direct stimulation of KATPchannels by exogenous and endogenous hydrogen sulfide in vascularsmooth muscle cells. Mol. Pharmacol., 2005; 69: 1757-1764
  Google Scholar
• 37. Tanizawa K.: Production of H2S by 3-mercaptopyruvate sulphurtransferase.J. Biochem., 2011; 149: 357-359
  Google Scholar
• 38. Wallace J.L.: Hydrogen sulfide-releasing anti-inflammatorydrugs. Trends Pharmacol. Sci., 2007; 28: 501-505
  Google Scholar
• 39. Wallace J.L., Caliendo G., Santagada V., Cirino G.: Markedly reducedtoxicity of a hydrogen sulphide-releasing derivative of naproxen(ATB-346). Br. J. Pharmacol., 2010; 159: 1236-1246
  Google Scholar
• 40. Warenycia M.W., Goodwin L.R., Benishin C.G., Reiffenstein R.J.,Francom D.M., Taylor J.D., Dieken F.P.: Acute hydrogen sulfide poisoning.Demonstration of selective uptake of sulfide by the brainstem by measurement of brain sulfide levels. Biochem. Pharmacol,1989; 38: 973-981
  Google Scholar
• 41. Whiteman M., Armstrong J., Chu S.H., Jia-Ling S., Wong B.,Cheung N.S., Halliwell B., Moore P.K.: The novel neuromodulatorhydrogen sulfide: an endogenous peroxynitrite scavenger? J. Neurochem.,2004; 90: 765-768
  Google Scholar
• 42. Whiteman M., Li L., Kostetski I., Chu S.H., Siau J.L., Bhatia M.,Moore P.K.: Evidence for the formation of a novel nitrosothiol fromthe gaseous mediators nitric oxide and hydrogen sulphide. Biochem.Biophys. Res. Commun., 2006; 343: 303-310
  Google Scholar
• 43. Yang G., Wu L., Wang R.: Pro-apoptotic effect of endogenousH2S on human aorta smooth muscle cells. FASEB J., 2006; 20: 553-555
  Google Scholar
• 44. Yang W., Yang G., Jia X., Wu L., Wang R.: Activation of KATP channelsby H2S in rat insulin-secreting cells and the underlying mechanisms.J. Physiol., 2005; 569: 519-531
  Google Scholar
• 45. Zagli G., Patacchini R., Trevisani M., Abbate R., Cinotti S., GensiniG.F, Masotti G., Geppetti P.: Hydrogen sulfide inhibits human plateletaggregation. Eur. J. Pharmacol., 2007; 559: 65-68
  Google Scholar
• 46. Zhao W., Wang R.: H2S-induced vasorelaxation and underlyingcellular and molecular mechanisms. Am. J. Physiol. Heart Circ. Physiol.,2002; 283: H474-H480
  Google Scholar
• 47. Zhao W., Zhang J., Lu Y., Wang R.: The vasorelaxant effect ofH2S as a novel endogenous gaseous KATP channel opener. EMBO J.,2001; 20: 6008-6016
  Google Scholar

Full text